Literature DB >> 19625761

Oxidative stress-related proteins in a Conn's adenoma tissue. Relevance for aldosterone's prooxidative and proinflammatory activity.

L A Calò1, E Pagnin, P A Davis, D Armanini, P Mormino, G P Rossi, A C Pessina.   

Abstract

BACKGROUND AND AIM: Angiotensin II (Ang II) induces oxidative stress (OxSt), which is essential for cardiovascular remodeling. Aldosterone also induces fibrosis and remodeling through direct effect on non-classical mineralocorticoid (MR) target tissues. However, studies on the role of aldosterone on OxSt and related factors in humans are lacking.
MATERIALS AND METHODS: We assessed gene and protein expression of p22phox (RT-PCR and Western blot), NAD(P)H oxidase subunit essential for superoxide production and gene expression of transforming growth fator (TGF) beta, plasminogen activator inhibitor (PAI)-1, and heme oxygenase (HO)-1, effectors of OxSt (RT-PCR), in a Conn's adenoma, removed from a patient with primary hyperaldosteronism. Ang II type 1 (AT1R) and MR receptors expression were also evaluated (RT-PCR). The normal adrenal tissue adjacent to the adenoma was used as control.
RESULTS: p22phox gene and protein expression were higher (31% and 53%, respectively) in the adrenal adenoma. TGFbeta, PAI-1, and HO-1 gene expression were also higher (25%, 129%, and 25%, respectively) in the adrenal adenoma while AT1R gene expression was similar (8%). The expression of MR in the adenoma was documented.
CONCLUSIONS: This report demonstrates in a human model that the increased aldosterone production has effects on enzyme systems related to OxSt, enhancing the systemic fibrogenic effects of aldosterone excess through TGFbeta and PAI-1 expression which was previously demonstrated only indirectly in vitro and in animal models. The presence of MR expression in the adenoma may link the hormone with the adenoma growth. Therefore, the results of this study derived from a single case might represent an important working hypothesis for further research in a larger number of cases to clarify the role of aldosterone overproduction on OxSt and its clinical relevance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625761     DOI: 10.1007/BF03346549

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  34 in total

Review 1.  Oxidative stress as the triggering event for vascular remodelling.

Authors:  P Silacci; D Hayoz
Journal:  Nephrol Dial Transplant       Date:  1998-06       Impact factor: 5.992

2.  Aldosterone induces a vascular inflammatory phenotype in the rat heart.

Authors:  Ricardo Rocha; Amy E Rudolph; Gregory E Frierdich; Denise A Nachowiak; Beverly K Kekec; Eric A G Blomme; Ellen G McMahon; John A Delyani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

3.  Mineralocorticoid receptor antagonism in experimental atherosclerosis.

Authors:  Sanjay Rajagopalan; Damon Duquaine; Steven King; Bertram Pitt; Paresh Patel
Journal:  Circulation       Date:  2002-05-07       Impact factor: 29.690

Review 4.  Progression of chronic renal disease.

Authors:  S Klahr
Journal:  Heart Dis       Date:  2001 May-Jun

Review 5.  Role of oxidative stress in atherosclerosis.

Authors:  David Harrison; Kathy K Griendling; Ulf Landmesser; Burkhard Hornig; Helmut Drexler
Journal:  Am J Cardiol       Date:  2003-02-06       Impact factor: 2.778

Review 6.  Aldosterone: a risk factor for vascular disease.

Authors:  Mario Fritsch Neves; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

7.  Aldosterone induces myofibroblastic transdifferentiation and collagen gene expression through the Rho-kinase dependent signaling pathway in rat mesangial cells.

Authors:  Suwarni Diah; Guo-Xing Zhang; Yukiko Nagai; Wei Zhang; Liu Gang; Shoji Kimura; Mas R W Abdul Hamid; Takashi Tamiya; Akira Nishiyama; Hirofumi Hitomi
Journal:  Exp Cell Res       Date:  2008-10-07       Impact factor: 3.905

8.  Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.

Authors:  Ricardo Rocha; Cynthia L Martin-Berger; Pochang Yang; Rachel Scherrer; John Delyani; Ellen McMahon
Journal:  Endocrinology       Date:  2002-12       Impact factor: 4.736

9.  Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling.

Authors:  Lorenzo A Calò; Elisa Pagnin; Paul A Davis; Michelangelo Sartori; Andrea Semplicini
Journal:  Nephrol Dial Transplant       Date:  2003-08       Impact factor: 5.992

10.  Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.

Authors:  D T Eitzman; R D McCoy; X Zheng; W P Fay; T Shen; D Ginsburg; R H Simon
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

View more
  11 in total

1.  Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry.

Authors:  A Grotevendt; H Wallaschofski; M Reincke; C Adolf; M Quinkler; M Nauck; W Hoffmann; R Rettig; A Hannemann
Journal:  Endocrine       Date:  2017-06-22       Impact factor: 3.633

Review 2.  Review of Markers of Zona Glomerulosa and Aldosterone-Producing Adenoma Cells.

Authors:  Teresa M Seccia; Brasilina Caroccia; Elise P Gomez-Sanchez; Paul-Emmanuel Vanderriele; Celso E Gomez-Sanchez; Gian Paolo Rossi
Journal:  Hypertension       Date:  2017-09-25       Impact factor: 10.190

Review 3.  Diagnosis and treatment of primary aldosteronism.

Authors:  Gian Paolo D Rossi
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

4.  Some Considerations About Primary Aldosteronism and Its Follow-Up.

Authors:  Decio Armanini; Chiara Sabbadin; Alessandra Andrisani; Guido Ambrosini; Luciana Bordin
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-19       Impact factor: 3.738

5.  Interrelationship Between Vitamin D Insufficiency, Calcium Homeostasis, Hyperaldosteronism, and Autoimmunity.

Authors:  Decio Armanini; Alessandra Andrisani; Guido Ambrosini; Gabriella Donà; Valentina Camozzi; Luciana Bordin; Chiara Sabbadin
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-04-21       Impact factor: 3.738

6.  Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress.

Authors:  K Ketola; M Hilvo; T Hyötyläinen; A Vuoristo; A-L Ruskeepää; M Orešič; O Kallioniemi; K Iljin
Journal:  Br J Cancer       Date:  2012-01-03       Impact factor: 7.640

7.  Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population.

Authors:  Vin-Cent Wu; Kuo-How Huang; Kang-Yung Peng; Yao-Chou Tsai; Che-Hsiung Wu; Shuo-Meng Wang; Shao-Yu Yang; Lian-Yu Lin; Chin-Chen Chang; Yen-Hung Lin; Shuei-Liong Lin; Tzong-Shinn Chu; Kwan-Dun Wu
Journal:  Sci Rep       Date:  2015-06-12       Impact factor: 4.379

8.  Role of Nox2 and p22phox in Persistent Postoperative Hypertension in Aldosterone-Producing Adenoma Patients after Adrenalectomy.

Authors:  Xiaojing Geng; Li Yan; Jun Dong; Ying Liang; Yajuan Deng; Ting Li; Tongfeng Luo; Hailun Lin; Shaoling Zhang
Journal:  Int J Endocrinol       Date:  2016-02-16       Impact factor: 3.257

9.  Transcriptome Pathway Analysis of Pathological and Physiological Aldosterone-Producing Human Tissues.

Authors:  Junhua Zhou; Brian Lam; Sudeshna G Neogi; Giles S H Yeo; Elena A B Azizan; Morris J Brown
Journal:  Hypertension       Date:  2016-10-24       Impact factor: 10.190

Review 10.  ROCK (RhoA/Rho Kinase) in Cardiovascular-Renal Pathophysiology: A Review of New Advancements.

Authors:  Teresa M Seccia; Matteo Rigato; Verdiana Ravarotto; Lorenzo A Calò
Journal:  J Clin Med       Date:  2020-05-02       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.